Key data
| Regulation | Commission Implementing Decision (EU) 2026/2559 of 19 November 2026 |
|---|---|
| Official reference | OJ:L_202602559 |
| Publication | 20 November 2026 |
| Entry into force | Not specified in the decision |
| Affected substance | N,N-diethyl-meta-toluamide (DEET) |
| Type of biocidal product | Type 19 — Repellents for insects and other arthropods |
| Regulatory framework | Regulation (EU) No 528/2012 of the European Parliament and of the Council |
| Affected parties | Manufacturers and distributors of insect repellent biocides with DEET in the EU |
| Category | European Regulation |
Manufacturers and distributors of insect repellents with DEET in the European Union have the green light to continue their activities without interruption. Commission Implementing Decision (EU) 2026/2559, published on 20 November 2026, delays the expiration date of the approval of N,N-diethyl-meta-toluamide (DEET) for use in biocides of product type 19, which encompasses insect repellents and other arthropods.
This extension occurs because the evaluation process for renewing DEET approval has not been completed before the original expiration date, a common situation under the Regulation (EU) No 528/2012 on biocides. The Commission acts preventively to avoid a legal vacuum that would force products to be withdrawn from the market while technical evaluation continues.
What does this regulation establish?
The decision has a very specific technical and administrative scope: it extends the validity period of DEET approval as an active substance for type 19 biocides, without modifying any of the current usage conditions or authorization requirements for products already containing this substance.
The key points of what this decision establishes and what it does NOT establish are as follows:
| Aspect | What does the decision say? |
|---|---|
| Expiration date of DEET approval | Delayed (extended) from the original date |
| DEET usage conditions | No changes — current conditions remain in place |
| Authorization requirements for DEET-containing products | No changes — no new authorizations required |
| Operational continuity for manufacturers and distributors | Guaranteed — can continue marketing without interruption |
| Definitive renewal outcome | Pending — will be resolved upon completion of the evaluation process |
The extension mechanism is provided for in Regulation (EU) 528/2012 itself to prevent companies from being in a situation of illegality while technical bodies complete the renewal evaluation. It does not imply any positive or negative judgment on the substance: it is an administrative continuity measure.
Economic and operational impact
For companies in the sector, the immediate impact of this decision is neutral and positive: there are no additional costs, no new obligations, and no risk of business interruption. The extension eliminates short-term uncertainty.
However, the strategic impact in the medium term does merit attention:
- Uncertainty about future conditions: The definitive renewal process for DEET may conclude with more restrictive usage conditions, new labeling requirements, concentration limitations, or even, in the worst-case scenario, non-renewal of approval. Companies must monitor its progress closely.
- Product planning: While renewal is not resolved, companies cannot plan with certainty the future formulations of their products or investments in new DEET-containing product lines.
- No immediate adaptation costs: Since usage conditions and authorization requirements are not being modified, no reformulation costs, re-labeling, or new administrative procedures are generated at this time.
- Risk of future impact: If definitive renewal imposes new conditions, companies will need to adapt their products and authorizations, which will entail operational and administrative costs.
Who does it affect?
- Manufacturers of type 19 biocides that use DEET as an active substance in their insect and arthropod repellent formulations.
- Distributors and marketers of biocidal products with DEET in the European Union market.
- Holders of biocidal product authorizations that contain DEET as an active ingredient.
- Importers of biocidal products with DEET from third countries that market in the EU.
- Regulatory advisors and compliance departments of companies in the biocides, cosmetics with repellent function, and personal protective products sectors.
It does not affect manufacturers of other types of biocidal products that do not use DEET, nor companies in sectors other than biocides and insect repellents.
Practical example
A Spanish company manufacturing insect repellents in spray format with 20% DEET as an active substance, marketed under the category of type 19 biocides, had planned to review its product strategy in light of the possible expiration of DEET approval.
With the publication of Commission Implementing Decision (EU) 2026/2559, this company does not need to take any immediate action: its products remain legal, its authorizations are valid, and its commercial activity is not interrupted. There is no need to reformulate, re-label, or request new authorizations for now.
What this company should do is activate monitoring of the renewal process with the European Chemicals Agency (ECHA), since when that process concludes, the conditions for DEET use could change and require adaptations in formulation, labeling, or regulatory documentation.
What should companies do now?
- Verify that marketed products fall under type 19: Confirm that the DEET biocides in your portfolio effectively correspond to the category of insect and arthropod repellents (product type 19) covered by this extension.
- Keep product authorizations current: The extension does not exempt companies from maintaining national or Union authorizations for DEET-containing biocidal products in good standing. Review expiration dates of your own authorizations.
- Activate monitoring of the DEET renewal process: Monitor publications from the ECHA and the EU Official Journal to learn when the renewal evaluation concludes and what the definitive conditions will be.
- Do not make formulation changes or re-labeling based on this decision: The extension does not impose any modifications. Acting prematurely would generate unnecessary costs.
- Prepare a contingency plan: Internally evaluate what a renewal scenario with more restrictive conditions or, in the most extreme case, non-renewal of DEET would mean for the business. Having identified alternatives to active substances can be strategically relevant.
Frequently asked questions
Can I continue manufacturing and selling DEET-containing products after this decision?
Yes. Commission Implementing Decision (EU) 2026/2559 guarantees operational continuity: manufacturers and distributors of type 19 biocides with DEET can continue operating legally without any interruption. Usage conditions and authorization requirements for existing products have not been modified.
What is product type 19 in biocides?
Product type 19, according to Regulation (EU) No 528/2012, corresponds to repellents and attractants for insects and other arthropods. It is the category under which personal and environmental insect repellents containing DEET as an active substance are classified.
When will DEET approval renewal be definitively resolved?
The decision does not specify a specific date for resolving the renewal process. The extension has been granted precisely because that evaluation process has not been completed on time. Companies must monitor ECHA publications and the EU Official Journal to learn the outcome.
What can change when DEET's definitive renewal is resolved?
The definitive resolution of the renewal process will determine the future conditions for DEET use in the EU. It could involve changes in maximum permitted concentrations, labeling requirements, usage restrictions, or, in the most unfavorable scenario, non-renewal of approval. This is why it is important to follow the process closely.
Does this extension affect other types of biocidal products with DEET other than type 19?
No. Commission Implementing Decision (EU) 2026/2559 refers exclusively to the use of DEET in type 19 biocidal products (insect and arthropod repellents). If DEET is used in other biocide categories, this extension does not apply directly to them.
Official source
Consult the complete regulation in official source
Disclaimer: This article is for informational purposes only and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://eur-lex.europa.eu/./legal-content/AUTO/?uri=OJ:L_202602559